RxDoctor Payments Data

Victoria Stabinski, APRN

Nurse Practitioner · Chicago, ILNPI 1881099109

Payments from drug & device makers

$757in general payments, 2019–2025

Across 33 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$111
  • Sanofi-aventis U.S. LLC$99
  • Pharmacyclics LLC, An Abbvie Company$87
  • E.r. Squibb & Sons, L.L.C.$59
  • Regeneron Healthcare Solutions, Inc.$54
  • Genentech USA, Inc.$46
  • plus $301 from 14 others

What the payments were for

  • Food & beverage$61581%
  • Education$14219%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$757 in reported general payments places this provider in the 75th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$6,430
Medicare patients
40
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib51$802,556
EliquisApixaban20$13,063
XareltoRivaroxaban15$11,362
Exemestane33$8,631
Letrozole98$2,208
Anastrozole65$1,417
Prochlorperazine Maleate20$282
Alendronate Sodium15$277
Tamoxifen Citrate16$234
Gabapentin35$219
Venlafaxine Hcl ErVenlafaxine Hcl11$198
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$176
Fluoxetine Hcl11$73

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerIbrance, Eliquis$20$815,62071 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →